Chicken-Derived Humanized Antibody Targeting a Novel Epitope F2pep of Fibroblast Growth Factor Receptor 2: Potential Cancer Therapeutic Agent

• Keng-Chang Tsai,
• Chao-Di Chang,
• Ming-Hui Cheng,
• Tsai-Yu Lin,
• Yan-Ni Lo,
• Tz-Wen Yang,
• Fu-Ling Chang,
• Chen-Wei Chiang,
• Yu-Ching Lee,
• Yun Yen

Affiliations

Keng-Chang Tsai

National Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taipei, Taiwan

Chao-Di Chang

§Ph.D. Program in Biotechnology Research and Development, College of Pharmacy, Taipei Medical University, Taipei, Taiwan

Ming-Hui Cheng

Department of Laboratory Medicine, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan, Taiwan

Tsai-Yu Lin

∥TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei, Taiwan

Yan-Ni Lo

∥TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei, Taiwan

Tz-Wen Yang

∥TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei, Taiwan

Fu-Ling Chang

⊥Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan

Chen-Wei Chiang

§Ph.D. Program in Biotechnology Research and Development, College of Pharmacy, Taipei Medical University, Taipei, Taiwan

Yu-Ching Lee

∥TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei, Taiwan

Yun Yen

∥TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei, Taiwan